We present an economic plan for a collective sharing of scientific knowledge on the pandemic.

Federal grant support for technology transfer at universities will strengthen the national innovation system.

The same Winnipeg lab that sent Ebola and Henipah viruses to Beijing recently removed a number of researchers for an “administrative issue.”

Hundreds of CRISPR patents have been granted around the world, and the number of applications continues to grow at a rapid pace.

The US patent office declares an interference between the intellectual property held by the Broad Institute and several patent applications filed by the University of California—opposite its previous ruling.

The group had argued that a patent given to the Broad Institute overlapped with this one.

The higher court’s decision to uphold the ruling of the Patent Trial and Appeal Board essentially ends the intellectual property battle in the US.

Almost half of all patents relating to the genes of marine organisms belong to one large international corporation, BASF, a new study reveals.  

LabCorp might be able to charge a licensing fee to any scientists who wish to sequence the gene HOMER1 in people who may have autism.

In an ongoing legal battle, the University of California, Berkeley has challenged the Broad Institute’s patent claims on the gene editing technology.

An investigation of 2.7 million patent submissions in the U.S. finds gender disparities throughout the application process.

This is the second patent the European Patent Office has issued to the institutions of Jennifer Doudna, Emmanuelle Charpentier, and colleagues.

In efforts to translate basic-science results into pharmaceuticals and other technologies, success cannot be taken for granted.

Gender discrimination, Brexit, and climate change are among the issues that have received considerable attention from the scientific community this year.

Hurricanes, protests, and lifesaving genetic engineering: our picks for the biggest stories of the year

The battle for the control of the intellectual property surrounding CRISPR-Cas9 is as storied and nuanced as the technology itself.

New rankings highlight institutions that have produced large numbers of articles cited in others' patents.

The University of California files a brief in its appeal challenging the ruling that the Broad Institute’s group would retain its CRISPR genome-editing patent.

Around 8 percent of grants funded by the National Institutes of Health resulted in patents.